Veedol Corporation Limited has officially completed the closure of its wholly owned subsidiary Veedol Deutschland GmbH in Germany, with the liquidation now formally entered in the German commercial register. The company announced this development on January 15, 2026, marking the completion of a closure process that was initially disclosed on May 18, 2024.

Closure Details and Timeline

The closure represents the final step in the liquidation process of the German subsidiary. Veedol Corporation has emphasized that this closure will not have any impact on the company's business operations, suggesting the subsidiary had minimal operational significance to the parent company's core activities.

Financial Impact Assessment

The subsidiary's financial contribution to Veedol Corporation was negligible, as detailed in the regulatory disclosure. During the last financial year, Veedol Deutschland GmbH contributed nil amounts across all key financial metrics.

Regulatory Compliance

Veedol Corporation has fulfilled its disclosure obligations under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company provided comprehensive details as required pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.

The transaction does not constitute a sale or disposal, as it represents a closure of operations rather than a transfer to third parties. Consequently, considerations related to sale agreements, buyer details, related party transactions, and arms-length pricing are not applicable to this closure.

Corporate Structure Simplification

The closure of Veedol Deutschland GmbH represents a streamlining of Veedol Corporation's international subsidiary structure. Given the subsidiary's nil contribution to financial performance, this closure appears to be part of operational efficiency measures without affecting the company's core business activities or revenue streams.

Veedol Corporation Limited has successfully obtained ISO 31000:2018 Risk Management certification, marking a significant milestone in the company's commitment to robust risk management practices. The certification was awarded by Bureau Veritas India Private Limited following a comprehensive onsite assessment.

Certification Details

The company received email communication from Bureau Veritas India confirming the successful completion of ISO 31000:2018 Onsite Assessment Certification on December 11, 2025, at 3:11 PM. The assessment itself was conducted on December 10, 2025, demonstrating the efficiency of the evaluation process.

Scope of Certification

The ISO 31000:2018 certification encompasses enterprise risk management for all supporting processes across multiple business functions. The comprehensive scope includes:

• Corporate governance
• Financial management
• Manufacturing operations
• Information technology systems
• Sales and marketing activities
• Human resource management
• Research and development for lubricants

Multi-Site Coverage

The certification covers multiple locations of Veedol Corporation Limited:

Regulatory Compliance

The certification announcement was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. This demonstrates the company's commitment to maintaining transparency with stakeholders and adhering to regulatory requirements.

Certification Validity

The ISO 31000:2018 certification remains valid until December 9, 2028, subject to continued satisfactory compliance during periodical assessments by Bureau Veritas. This three-year validity period reflects the comprehensive nature of the risk management framework implemented by the company across its operations.